Do psychological factors influence the course of cancer? Findings, methods, and mechanisms

Zeitschrift fur Medizinische Psychologie

Volumn 13, Issue 3, 2004, Pages 99-108

  Faller, Hermann ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Breast cancer; Coping; Lung cancer; Prognostic factors; Survival

Indexed keywords

EID: 85013576385     PISSN: 09405569     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Altman, D.G., De Stavola, B.L., Love, S.B., Stepniewska (1995). Review of survival analyses published in cancer journals. British Journal of Cancer, 72, 511-518.
2. Altman, D.G., Lausen, B., Sauerbrei, W., Schumacher, M. (1994). Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J. Natl. Cancer Inst., 86, 829-835.
3. Altman, D.G., Lyman, G.H. (1998). Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Research and Treatment, 52, 289-303.
4. Andersen, B.L., Farrar, W.B., Golden-Kreutz, D., Kutz, L.A., MacCallum, R., Courtney, M.E., Glaser, R. (1998). Stress and immune responses after surgical treatment for regional breast cancer. J. Natl. Cancer Inst., 90, 30-36.
5. Andersen, B.L., Kiecolt-Glaser, J.K., Glaser, R. (1994). A biobehavioral model of cancer stress and disease course. American Psychologist, 49, 389-404.
6. Bovbjerg, D.H., Valdimarsdottir, H.B. (1998). Psychoneuroimmunology: Implications for psycho-oncology. In J.C. Holland (Ed.), Psycho-oncology (125-134). New York: Oxford University Press.
7. Buccheri, G. (1998). Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur. Respir. J., 11, 173-178.
8. Buddeberg, C., Sieber, M., Wolf, C., Landolt-Ritter, C., Richter, D., Steiner, R. (1996). Are coping strategies related to disease outcome in early breast cancer? J. Psychosom. Res., 40, 255-264.
9. Christensen, E. (1987). Multivariate survival analysis using Cox’s regression model. Hepatology, 7, 1346-1358.
10. Classen, C., Sephton, S. E., Diamond, S., Spiegel, D. (1998). Studies of life-extending psychosocial interventions. In J. C. Holland (Ed.) Psycho-oncology (730-742). New York: Oxford University Press
11. Cody, M., Nichols, S., Brennan, C., Armes, J., Wilson, P., Slevin, M. (1994). Psychosocial factors and lung cancer prognosis (abstract). Psycho-Oncology, 3, 141.
12. Colleoni, M., Mandala, M., Peruzzotti, G., Robertson, C., Bredart, A., Goldhirsch, A. (2000). Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet, 356, 1326-1327.
13. Cunningham, A.J., Edmonds, C.V.I., Jenkins, G.P., Pollack, H., Lockwood, G.A., Warr, D.(1998). A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psycho-Oncology, 7, 508-517.
14. Dean, C., Surtees, P.G. (1989). Do psychological factors predict survival in breast cancer? J. Psychosom. Res., 33, 561-569.
15. Derogatis, L.R., Abeloff, M.D., Melisaratos, N. (1979). Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA, 242, 1504-1508.
16. Edelman, S., Lemon, J., Bell, D.R., Kidman, A.D. (1999). Effects of group CBT on the survival time of patients with metastatic breast cancer. Psycho-Oncology, 8, 474-481.
17. Faller, H., Bülzebruck, H., Drings, P., Lang, H. (1999). Coping, distress, and survival among patients with lung cancer. Arch. Gen. Psychiat., 56, 756-762.
18. Faller, H., Bülzebruck, H. (2002). Coping and survival in lung cancer: A 10-year follow-up. Am. J. Psychiatry, 159, 2105-2107.
19. Faller, H., Schmidt, M. (2004). Prognostic value of depressive coping and depression regarding survival in lung cancer patients. Psycho-Oncology (in press).
20. Faller, H. (2001). Krankheitsbewältigung und Überlebenszeit bei Krebskranken. Literaturübersicht und Ergebnisse einer Untersuchung mit Lungenkrebspatienten. Psychotherapeut., 46, 20-35.
21. Fischer, J.R., Schindel, M., Bülzebruck, H., Lahm, H., Krammer, P.H., Drings, P. (1997a). Decrease of interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer. Ann. Oncol., 8, 457-461.
22. Fischer, J.R., Schindel, M., Lahm, H., Drings, P. (1997b). Tumour-derived, endocrine, exogenous and therapeutic factors differentially modulate cytokine secretion in whole blood cell culture. Eur. J. Cancer, 33, 1661-1667.
23. Fischer, J.R., Schindel, M., Bülzebruck, H., Lahm, H., Krammer, P.H., Drings, P. (2000). Long-term survival in small cell lung cancer patients is correlated with high interleukin-2 secretion at diagnosis. J. Cancer Res. Clin. Oncol., 126, 730-733.
24. Fox, B.H. (1998a). Psychosocial factors in cancer incidence and prognosis In J.C. Holland (Ed.), Psycho-Oncology (110-124). New York: Oxford University Press.
25. Fox, B. (1998b). A hypothesis about Spiegel et al.‘s 1989 paper on psychosocial intervention and breast cancer survival. Psycho-Oncology, 7, 361-370.
26. Gilbar, O., Kaplan-De Nour, A., (1989). Adjustment to illness and drop-out of chemotherapy. J. Psychosom. Res., 33, 1-5.
27. Gilbar, O. (1996). The connection between the psychological condition of breast cancer patients and survival. A follow-up after eight years. General Hospital Psychiatry, 18, 266-270.
28. Giraldi, T., Rodani, M.G., Cartei, G., Grassi, L. (1997). Psychosocial factors and breast cancer: A 6-year Italian follow-up study. Psychother. Psychosom., 66, 229-236.
29. Goodwin, P.J., Leszcz, M., Ennis, M., Koopmans, J., Vincent, L., Guther, H., Drysdale, E., Hundleby, M., Chochinov, H.M., Navarro, M., Speca, M., Hunter, J. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. New Engl. J. Med., 345, 1719-1726.
30. Greer, S., Morris, T., Pettingale, K.W., Haybittle, J.L. (1990). Psychological response to breast cancer and 15 year outcome. Lancet, I, 49-50.
31. Hislop, G.T., Waxler, N.E., Coldman, A.J., Elwood, J.M., Kan, L. (1987). The prognostic significance of psychosocial factors in women with breast cancer. J. Chronic Dis., 40, 729-735.
32. Hjerl, K., Andersen, E.W., Keiding, N., Mouridsen, H.A.T., Mortensen, P.B., Jorgensen, T.(2003). Depression as a prognostic factor for breast cancer mortality. Psychosomatics, 44, 24-30.
33. Holland, J.C., Korzun, A.H., Tross, S., Cella, D.F., Norton, L., Wood, W. (1986). Psychosocial factors and disease-free survival in stage II breast cancer. Proc. Am. Soc. Clin. Oncol., 5, 237.
34. Jamison, R.N., Burish, T.G., Wallston, K.A. (1987). Psychogenic factors in predicting survival of breast cancer patients. J. Clin. Oncol., 5, 768-772.
35. Jensen, M.R. (1987). Psychological factors predicting the course of breast cancer. J. Pers., 55, 317-342.
36. Kaasa, S., Mastekaasa, A., Lund, E. (1989). Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. Radiother Oncol., 15,235-242.
37. Karnofsky, D.A., Burchenal, J.H. (1949). The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod, C.M. (ed.) Evaluation of chemotherapeutic agents. New York: Columbia University Press.
38. Kiecolt-Glaser, J., McGuire, L., Robles, T.F., Glaser, R. (2002). Psychoneuroimmunology: Psychological influences on immune function and health. J. Consult Clin. Psychol., 70, 537-547.
39. Kraemer, H.C., Kazdin, A.E., Offord, D.R., Kessler, R.C., Jensen, P.S., Kupfer, D.J. (1997). Coming to terms with the tems of risk. Arch. Gen. Psychiatry, 54, 337-343.
40. Kreitler, S., Kreitler, H., Chaitchik, S., Shaked, S., Shaked, T. (1997). Psychological and medical predictors of disease course in breast cancer: A prospective study. European J. Pers., 11, 383-400.
41. Levy, S.M., Herberman, R.B., Lippman, M., D’Angelo, T., Lee J. (1991). Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behavioral Medicine, 17, 67-75.
42. MacMahon, S., Collins, R. (2001). Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. Lancet, 357, 455-462.
43. Massie, M. J., Popkin, M. K. (1998). Depressive disorders. In J. C. Holland (ed.) Psycho-oncology, 518-540. New York: Oxford University Press.
44. Morris, T., Pettingale, K., Haybittle, J. (1992). Psychological response to cancer diagnosis and disease outcome in patients with breast cancer and lymphoma. Psycho-Oncology, 1, 105-114.
45. Murr, C., Widner, B., Sperner-Unterweger, B., Ledochowski, M., Schubert, C., Fuchs, D. (2000). Immune reaction links disease progression in cancer patients with depression. Med. Hypotheses, 55, 137-140.
46. Neuner, A., Schindel, M., Wildenberg, U., Muley, T., Lahm, H., Fischer, J.R. (2002). Prognostic significance of cytokine modulation in non-small cell lung cancer. Int. J. Cancer, 101, 287-292.
47. Petticrew, M., Fraser, J. M., Regan, M.F. (1999). Adverse life-events and risk of breast cancer: A meta-analysis. British Journal of Health Psychology, 4, 1-17.
48. Petticrew, M., Bell, R., Hunter, D. (2002). Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ, 325, 1066.
49. Reynolds, P., Hurley, S., Torres, M., Jackson, J., Boyd, P., Chen, V.W., and the Black/White Cancer Survival Study Group. (2000). Use of coping strategies and breast cancer survival: Results from the Black/White Cancer Survival Study. Am. J. Epidemiol., 152, 940-949.
50. Ross, L., Boesen, E. H., Dalton, S. O., Johansen, C. (2002). Mind and cancer: does psychosocial intervention improve survival and psychological well-being? Eur. J. Cancer, 38, 1447-1457.
51. Sackett, D.L., Straus, S.E., Richardson, W.S., Rosenberg, W., Haynes, R.B. (2000). Evidencebased medicine. 2nd ed. Edinburgh: Churchill Livingstone.
52. Sephton, S.E., Sapolsky, R.M., Kraemer, H.C., Spiegel, D. (2000). Diurnal cortisol rhythm as a predictor of breast cancer survival.J. Natl. Cancer Inst., 92, 994-1000.
53. Simon, R., Altman, D.G. (1994). Statistical aspects of prognostic factor studies in oncology. Br. J. Cancer, 69, 979-985.
54. Spiegel, D., Bloom, J.R., Kraemer, H.C., Gottheil, E. (1989). Effect of psychosocial treat ment on survival of patients with metastatic breast cancer. Lancet, October 14, 888-891.
55. Tibshirani, R. (1982). A plain man’s guide to the proportional hazards model. Clinical & Investigational Medicine, 5, 63-68.
56. Trikas, P., Vlachonikolis, I., Samonis, G., Askoxilakis, I., Tsiftsis, D., Koutoubi, K., Paritsis, N. (2002). Low psychopathology scores in the prognosis of breast cancer. Psychother. Psychosom., 71, 162-167.
57. Tross, S., Herdon, I.I.J., Korzun, A., Kornblith, A.B., Cella, D.F., Holland, J.F., Raich, P., Johnson, A., Kiang, D.T., Perloff, M., Norton, L., Wood, W., Holland, J.C., from the Cancer and Leukemia Group. (1996). Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. J. Natl. Cancer Inst., 88, 661-667.
58. Watson, M., Haviland, J.S., Greer, S., Davidson, J., Bliss, J.M. (1999). Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet, 354, 1331-1336.
59. Weihs, K.L., Enright, T.M., Simmens, S.J., Reiss, D. (2000). Negative affectivity, restriction of emotions, and site of metastases predict mortality in recurrent breast cancer. J. Psychosom. Res., 49, 59-68.